pifithrin has been researched along with Cognition Disorders in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, LY | 1 |
| Greig, NH | 1 |
| Huang, YN | 1 |
| Hsieh, TH | 1 |
| Tweedie, D | 1 |
| Yu, QS | 1 |
| Hoffer, BJ | 1 |
| Luo, Y | 1 |
| Kao, YC | 1 |
| Wang, JY | 1 |
1 other study available for pifithrin and Cognition Disorders
| Article | Year |
|---|---|
Post-traumatic administration of the p53 inactivator pifithrin-α oxygen analogue reduces hippocampal neuronal loss and improves cognitive deficits after experimental traumatic brain injury.
Topics: Aldehydes; Animals; Annexin A5; Apoptosis Regulatory Proteins; Benzothiazoles; Brain; Brain Injuries | 2016 |